Biology and relevance of human acute myeloid leukemia stem cells

D Thomas, R Majeti - Blood, The Journal of the American …, 2017 - ashpublications.org
Evidence of human acute myeloid leukemia stem cells (AML LSCs) was first reported nearly
2 decades ago through the identification of rare subpopulations of engrafting cells in …

Tumour heterogeneity and cancer cell plasticity

CE Meacham, SJ Morrison - Nature, 2013 - nature.com
Phenotypic and functional heterogeneity arise among cancer cells within the same tumour
as a consequence of genetic change, environmental differences and reversible changes in …

Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia

DA Pollyea, BM Stevens, CL Jones, A Winters, S Pei… - Nature medicine, 2018 - nature.com
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. Leukemia
stem cells (LSCs) drive the initiation and perpetuation of AML, are quantifiably associated …

The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells

LP Vu, BF Pickering, Y Cheng, S Zaccara, D Nguyen… - Nature medicine, 2017 - nature.com
Abstract N 6-methyladenosine (m6A) is an abundant nucleotide modification in mRNA that is
required for the differentiation of mouse embryonic stem cells. However, it remains unknown …

Inhibition of amino acid metabolism selectively targets human leukemia stem cells

CL Jones, BM Stevens, A D'Alessandro, JA Reisz… - Cancer cell, 2018 - cell.com
In this study we interrogated the metabolome of human acute myeloid leukemia (AML) stem
cells to elucidate properties relevant to therapeutic intervention. We demonstrate that amino …

Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism

T Farge, E Saland, F De Toni, N Aroua, M Hosseini… - Cancer discovery, 2017 - AACR
Chemotherapy-resistant human acute myeloid leukemia (AML) cells are thought to be
enriched in quiescent immature leukemic stem cells (LSC). To validate this hypothesis in …

Targeting the RNA m6A reader YTHDF2 selectively compromises cancer stem cells in acute myeloid leukemia

J Paris, M Morgan, J Campos, GJ Spencer… - Cell stem cell, 2019 - cell.com
Acute myeloid leukemia (AML) is an aggressive clonal disorder of hematopoietic stem cells
(HSCs) and primitive progenitors that blocks their myeloid differentiation, generating self …

A 17-gene stemness score for rapid determination of risk in acute leukaemia

SWK Ng, A Mitchell, JA Kennedy, WC Chen, J McLeod… - Nature, 2016 - nature.com
Refractoriness to induction chemotherapy and relapse after achievement of remission are
the main obstacles to cure in acute myeloid leukaemia (AML). After standard induction …

Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche

H Ye, B Adane, N Khan, T Sullivan, M Minhajuddin… - Cell stem cell, 2016 - cell.com
Adipose tissue (AT) has previously been identified as an extra-medullary reservoir for
normal hematopoietic stem cells (HSCs) and may promote tumor development. Here, we …

BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation

S Raffel, M Falcone, N Kneisel, J Hansson, W Wang… - Nature, 2017 - nature.com
The branched-chain amino acid (BCAA) pathway and high levels of BCAA transaminase 1
(BCAT1) have recently been associated with aggressiveness in several cancer entities …